<DOC>
	<DOCNO>NCT02094326</DOCNO>
	<brief_summary>The purpose study find pattern use non-biological DMARDs initial treatment RA adverse event ( AEs ) , intolerance lack efficacy may impact therapeutic decision real life Spanish Andalusian region .</brief_summary>
	<brief_title>Study Assess Management Synthetic Disease-modifying Antirheumatic Drug ( DMARD ) Onset Adverse Events , Intolerance Lack Efficacy Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Patients sex â‰¥ 18 year . Patients diagnose RA ( accord American College Rheumatology ( ACR ) 2010 criterion ) January 2008 December 2012 initiate treatment least one synthetic DMARD period . Patients give write informed consent data collect review . Patients already participate clinical trial/s moment participation study . Patients suspect insufficient information complete study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>